BioCanRx: Funding Opportunities
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline: Wednesday 26th, October 2016
External Deadline: Wednesday 9th, November 2016
Description
BioCanRx has set the next intake date for funding applications in ​their rolling, open call process. BioCanRx builds on past and ongoing investments in the area of cancer biotherapeutics that have a clear path to, or are ready for, clinical trials. ​The network is strengthening Canada’s ability to translate the unfolding promise of immune-based cancer therapies into benefits for patients.
As an open call, this opportunity is open to all investigators located at Canadian institutions eligible to receive peer-reviewed funding from the three federal research-granting councils (CIHR, SSHRC, NSERC).
LOIs are now being accepted for the​ four research programs:
· Clinical Trials Program
· Enabling Studies Program
· Catalyst Program
· Clinical, Social and Economic Impact Program
If you have questions regarding your eligibility (or that of your institution) or how your project would fit within
​BioCanRx’s research program, you are encouraged to contact Dr. Kelley Parato, Director of Scientific Affairs at BioCanRx.
Important Dates:
The next intake deadline is November 9, 2016, by 11:59 p.m. EDT.
Contact information:
For more information, see the Apply for Funding page at the BioCanRx website or contact:
Dr. Kelley Parato
Tel: 613-739-6595
Email: keparato@biocanrx.com